SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-22-000743
Filing Date
2022-02-10
Accepted
2022-02-10 12:29:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 PRIMECAP MANAGEMENT CO/CA/ wvea2_21022.htm SC 13G/A 26334
  Complete submission text file 0001085146-22-000743.txt   28100
Mailing Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105
Business Address 177 EAST COLORADO BLVD. 11TH FLOOR PASADENA CA 91105 6263049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

IRS No.: 953868081
Type: SC 13G/A

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Subject) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89180 | Film No.: 22612518
SIC: 2834 Pharmaceutical Preparations